4//SEC Filing
NovaBay Pharmaceuticals, Inc. 4
Accession 0001437749-15-018137
$NBYCIK 0001389545operating
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 8:23 PM ET
Size
5.1 KB
Accession
0001437749-15-018137
Insider Transaction Report
Form 4
Stroman David W.
SVP, Ophthalmic Product Devt.
Transactions
- Award
Option (right to buy)
2015-10-05+100,000→ 474,834 totalExercise: $0.27From: 2016-10-05Exp: 2025-10-05→ common stock (100,000 underlying)
Footnotes (1)
- [F1]Options granted pursuant to the 2007 Omnibus Incentive Plan and NovaBay's Annual Employee Equity Refresh Program. 25% will vest on the first anniversary of the Grant Date. 6.25% will vest every three months thereafter.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 8:23 PM ET
- Size
- 5.1 KB